Th1 cell activation and cytokine production shift the balance between Th1 and Th2, favoring the upregulation of proinflammatory activity that leads to destruction of allogeneic hepatocytes following transplantation. Th2-type cytokines, such as IL-10, have immune regulatory function. The aim of this study was to determine the antirejection efficacy of allogeneic hepatocytes with spheroidal shape (spheroids) genetically modified with viral IL-10 (vIL-10). Allogeneic hepatocyte spheroids, transferred vIL-10 gene by using adenovirus as the vector, were transplanted into the spleen of Nagase's analbuminemic rats (NAR). NAR transplanted with vIL-10-transfected hepatocytes showed an abrupt rise in serum albumin levels that peaked on day 7 and remained at high levels up to day 21 after transplantation. The peak level of albumin on day 7 in vIL-10-transfected NAR was eminently higher than that in nontransfected NAR. Histopathological analysis revealed that in nontransfected NAR hepatocyte spheroids were more or less rejected on day 4, and, in contrast, vIL-10-transfected spheroids were still not rejected on day 14. This protective effect correlated with sustained high vIL-10 level in the splenic vein in NAR transplanted with vIL-10-transfected hepatocyte spheroids, suggesting that vIL-10 secreted from the transplanted hepatocytes induced an active suppression of allogeneic response. This study provides evidence to support the possibility of using vIL-10 gene therapy to prevent allogeneic response in hepatocyte transplantation.
BeckerJ. C.; CzernyC.; BrockerE. B.Maintenance of clonal anergy by endogenously produced IL-10.Int. Immunol.6: 1605–1612; 1994.
2.
BerryM. N.; FriendD. S.High-yield preparation of isolated rat liver parenchyma cells: A biochemical and time structural study.J. Cell Biol.43: 506–520; 1969.
3.
BogdanC.; VodovotzY.; NathanC.Macrophage deactivation by interleukin-10.J. Exp. Med.174: 1549–1555; 1991.
ChristiansonS. W.; ShultzL. D.; LeiterE. H.Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice: Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NOD-Thy-1a donors.Diabetes42: 44–55; 1993.
6.
CottrezF.; GrouxH.Regulation of TGF-β response during T cell activation is modulated by IL-10.J. Immunol.167: 773–778; 2001.
7.
CseteM. E.; DrazanK. E.; van BreeM.; McInteeD. F.; McBrideW. H.; BettA.; GrahamF. L.; BusuttilR. W.; BerkA. J.; ShakedA.Adenovirus-mediated gene transfer in the transplant setting.Transplantation57: 1502–1507; 1994.
8.
DengS.; KetchumR. J.; YangZ. D.; KucherT.; WeberM.; ShakedA.; NajiA.; BraymanK. L.IL-10 and TGF-β gene transfer to rodent islets: Effect on xenogeneic islet graft survival in näive and B-cell deficient mice.Transplant. Proc.29: 2207–2208; 1997.
9.
DengS.; YangZ. D.; KetchmanR. J.; KucherT.; WeberM.; ShakedA.; NajiA.; BraymanK. L.Transfer of genes for IL-10 and TGF-β to isolated human pancreatic islets.Transplant. Proc.29: 2206; 1997.
10.
de Waal MalefytR.; AbramsJ.; BennettB.; FigdorC. G.; de VriesJ. E.IL-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes.J. Exp. Med.174: 1209–1220; 1991.
11.
de Waal MalefytR.; MooreK. W.Interleukin-10. In: ThompsonA., ed. The cytokine handbook.London: Academic Press;1998: 333–398.
12.
de Waal MalefytR.; HaanenJ.; SpitsH.; RoncaroloM. G.; de VeldeA.; FigdorC.; JohnsonK.; KasteleinR.; YsselH.; de VriesJ. E.IL-10 and viral IL-10 strongly reduces antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II MHC expression.J. Exp. Med.174: 915–925; 1991.
13.
DingL.; LinsleyP. S.; HuangL. Y.; GermainR. N.; ShevachE. M.IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.J. Immunol.151: 1224–1234; 1993.
14.
DingL.; ShevachE. M.IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function.J. Immunol.148: 3133–3139; 1992.
15.
FiorentinoD. F.; BondM. W.; MosmannT. R.Two types of mouse T helper cell.IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med.170: 2081–2095; 1989.
16.
FiorentinoD. F.; ZlotnikA.; VieiraP.; MosmannT.; HowardM.; MooreK.; O'GarraA.IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.J. Immunol.146: 3444–3451; 1991.
17.
FiorentinoD. F.; ZlotnikA.; MosmannT. R.; HowardM.; O'GarraA.IL-10 inhibits cytokine production by activated macrophages.J. Immunol.147: 3815–3822; 1991.
18.
FlotteT.; AgarwalA.; WangJ.; SongS.; FenjvesE. S.; InverardiL.; ChesnutK.; AfioneS.; LoilerS.; WasserfallC.Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors.Diabetes50: 515–520; 2001.
19.
FujisawaK.; SaitoS.; OkadaY.; FujiwaraT.; OtaK.; TanakaN.Possibility of gene transfer to the hepatic graft under cold preservation conditions.Transplant. Proc.30: 2911–2912; 1998.
20.
GazzinelliR. T.; OswaldI. P.; JamesS. L.; SherA.IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.J. Immunol.148: 1792–1796; 1992.
21.
GerardC.; BruynsC.; MarchantA.; AbramowiczD.; DelvauxA.; FiersW.; GoldmanM.; VeluT.Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.J. Exp. Med.177: 547–550; 1993.
22.
GoN. F.; CastleB. E.; BarrettR.; KasteleinR.; DangW.; MosmannT. R.; MooreK. W.; HowardM.Interleu-in-10 (IL-10), a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficiency B cells.J. Exp. Med.172: 1625–1631; 1990.
HenkeP. K.; DeBrununyeL. A.; StrieterR. M.; BrombergJ. S.; PrinceM.; KadellA. K.; SarkarM.; LondyF.; WakefieldT. W.Viral IL-10 gene transfer decreases inflammation and cell adhesion molecular expression in a rat model of venous thrombosis.J. Immunol.164: 2131–2141; 2000.
25.
HowardM.; O'GarraA.Biological properties of interleukin-10.Immunol. Today13: 198–200; 1992.
HsuD. H.; de Waal MalefytR.; FiorentinoD. F.; DangM.; VieiraP.; de VriesJ.; SpitsH.; MosmannT. R.; MooreK. W.Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.Science250: 830–832; 1990.
28.
IshidoN.; MatsuokaJ.; MatsunoT.; NakagawaK.; TanakaN.Induction of donor specific hyporesponsiveness and prolongation of cardiac allograft survival by jejunal administration of donor splenocytes.Transplantation68: 1377–1382; 1999.
29.
JudgeT. A.; DesaiN. M.; YangZ. D.; RostamiS.; AlonsoL.; ZhangH.; ChenY.; MarkmanJ. F.; DemateoR. P.; BakerC. F.Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival.Transplantation66: 426–434; 1998.
30.
KobayashiN.; MiyazakiM.; FukayaK.Transplantation of highly differentiated immortalized human hepatocytes to treat acute liver failure.Transplantation69: 202–207; 2000.
31.
KobayashiN.; FujiwaraT.; WestermanK. A.Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes.Science287: 1258–1262; 2000.
32.
KoideN.; SakaguchiK.; KoideY.Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments.Exp. Cell Res.186: 227–235; 1990.
33.
KrenskyA. M.; WeissA.; CrabtreeG.; DavisM. M.; ParhamP.T-lymphocyte-antigen interactions in transplant rejection.N. Engl. J. Med.322: 510–517; 1990.
34.
LuL.; GambottoA.; LeeW. C.; QianS.; BonhamC. A.; RobbinsP. D.Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients.Gene Ther.6: 554–563; 1999.
35.
MacNeilI. A.; SudaT.; MooreK. W.; MosmannT. R.; ZlotnikA.IL-10: A novel cytokine growth cofactor for mature and immature T cells.J. Immunol.145: 4167–4173; 1990.
36.
MaloyK. J.; PowrieF.Regulatory T cells in the control of immune pathology.Nat. Immunol.2: 816–822; 2001.
37.
MooreK. W.; VieiraP.; FiorentinoD. F.; TrounstineM. L.; KhanT. A.; MosmannT. R.Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1.Science248: 1230–1234; 1990.
MullerA.; SchmittL.; RafteryM.; SchonrichG.Paralysis of B7 co-stimulation through the effect of viral IL-10 on T cells as a mechanism of local tolerance induction.Eur. J. Immunol.28: 3488–3498; 1998.
40.
OtaK.; SaitoS.; HamasakiK.Transplantation of xenogeneic hepatocytes: Three-dimensionally cultured hepatocyte (spheroid) transplantation into the spleen.Transplant. Proc.28: 1430–1432; 1996.
41.
PeshwaM. V.; WuF. J.; SharpH. L.Mechanistics of formation and ultrastructuural evaluation of hepatocyte spheroids.In Vitro Cell. Dev. Biol. Anim.32: 197–203; 1996.
42.
PrasadK. M. R.; YangZ. D.; BleichD.; NadlerJ. L.Adeno-associated virus vector mediated gene transfer to pancreatic β cells.Gene Ther.7: 1553–1561; 2000.
43.
SaitoS.; SakagamiK.; KoideN.Transplantation of spheroidal aggregate cultured hepatocytes into the rat spleen.Transplant. Proc.21: 2374–2377; 1989.
44.
SaitoS.; SakagamiK.; MatsunoT.Long-term and proliferation of spheroidal aggregate cultured hepatocytes transplanted into the rat spleen.Transplant. Proc.24: 1520–1521; 1992.
45.
SeglenP. O.Preparation of isolated rat liver cells.Methods Cell Biol.13: 29–83; 1976.
46.
ShinjiT.; KoideN.; TsujiT.Glycosaminoglycans partially substitute for proteoglycans in spheroidal formation of adult rat hepatocytes in primary culture.Cell. Struct. Funct.13: 179–188; 1988.
47.
SussG.; ShortmanK.A subclass of dendritic cells kills CD4+ T cells via Fas/Fas-ligand-induced apoptosis.J. Exp. Med.183: 1789–1796; 1996.
48.
TakayamaT.; MorelliA. E.; OnaiN.; HiraoM.; MatsushimaK.; TaharaH.; ThomsonA. W.Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down-regulate C-C chemokine receptor 5 expression by myeloid dendritic cells: Impact on chemotactic responses and in vivo homing ability.J. Immunol.166: 7136–7143; 2001.
49.
TakayamaT.; NishiokaY.; LuL.; LotzeM. T.; TaharaH.; ThomsonA. W.Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T cell hyporesponsiveness.Transplantation66: 1567–1574; 1998.
50.
VieiraP.; de Waal MalefytR.; DangM. N.; JohnsonK. E.; KasteleinR.; FiorentinoD. F.; de VriesJ. E.; RoncaroloM. G.; MosmannT. R.; MooreK. W.Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRF1.Proc. Natl. Acad. Sci. USA88: 1172–1176; 1991.
